J Vet Sci.  2014 Mar;15(1):117-123. 10.4142/jvs.2014.15.1.117.

Photodynamic hyperthermal chemotherapy with indocyanine green: a novel cancer therapy for 16 cases of malignant soft tissue sarcoma

Affiliations
  • 1The United Graduated Veterinary Science, Yamaguchi University, Yamaguchi 753-8515, Japan.
  • 2Department of Veterinary Diagnostic Imaging, Faculty of Agriculture, Tottori University, Tottori 680-8553, Japan.
  • 3Department of Veterinary Surgery, Faculty of Agriculture, Tottori University, Tottori 680-8553, Japan. yokamoto@muses.tottori-u.ac.jp
  • 4Department of Veterinary Neurology and Oncology, Faculty of Agriculture, Tottori University, Tottori 680-8553, Japan.
  • 5Aino Animal Hospital, Shizuoka 437-0023, Japan.
  • 6Tokyo Animal Medical Center, Tokyo 167-0054, Japan.
  • 7Takayama Pet Clinic, Osaka 546-0003, Japan.
  • 8Tokyo Iken Co. Ltd. Tokyo 206-0802, Japan.

Abstract

Sixteen cases of malignant soft tissue sarcoma (STS; 10 canines and six felines) were treated with a novel triple therapy that combined photodynamic therapy, hyperthermia using indocyanine green with a broadband light source, and local chemotherapy after surgical tumor resection. This triple therapy was called photodynamic hyperthermal chemotherapy (PHCT). In all cases, the surgical margin was insufficient. In one feline case, PHCT was performed without surgical resection. PHCT was performed over an interval of 1 to 2 weeks and was repeated three to 21 times. No severe side effects, including severe skin burns, necrosis, or skin suture rupture, were observed in any of the animals. No disease recurrence was observed in seven out of 10 (70.0%) dogs and three out of six (50.0%) cats over the follow-up periods ranging from 238 to 1901 days. These results suggest that PHCT decreases the risk of STS recurrence. PHCT should therefore be considered an adjuvant therapy for treating companion animals with STS in veterinary medicine.

Keyword

cancer; chemotherapy; hyperthermia; PDT; soft tissue sarcoma

MeSH Terms

Animals
Antineoplastic Agents/*therapeutic use
Cat Diseases/drug therapy/surgery/*therapy
Cats
Combined Modality Therapy/veterinary
Dog Diseases/drug therapy/surgery/*therapy
Dogs
Hyperthermia, Induced/veterinary
Indocyanine Green/*therapeutic use
Photochemotherapy/veterinary
Photosensitizing Agents/*therapeutic use
Sarcoma/drug therapy/surgery/therapy/*veterinary
Antineoplastic Agents
Indocyanine Green
Photosensitizing Agents

Figure

  • Fig. 1 (A) Skin incision (arrow) in case C07. (B) PHCT was performed after surgery. The arrow indicates the broadband light source while the arrowheads indicate the thermometer and thermometer sensor.


Reference

1. Abels C, Karrer S, Bäumler W, Goetz AE, Landthaler M, Szeimies RM. Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi's sarcoma. Br J Cancer. 1998; 77:1021–1024.
Article
2. Bäumler W, Abels C, Karrer S, Weiβ T, Messmann H, Landthaler M, Szeimies RM. Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer. 1999; 80:360–363.
Article
3. Bostock DE, Dye MT. Prognosis after surgical excision of canine fibrous connective tissue sarcomas. Vet Pathol. 1980; 17:581–588.
Article
4. Bozkulak O, Yamaci RF, Tabakoglu O, Gulsoy M. Photo-toxic effects of 809-nm diode laser and indocyanine green on MDA-MB231 breast cancer cells. Photodiagnosis Photodyn Ther. 2009; 6:117–121.
Article
5. Chen WR, Adams RL, Heaton S, Dickey DT, Bartels KE, Nordquist RE. Chromophore-enhanced laser-tumor tissue photothermal interaction using an 808-nm diode laser. Cancer Lett. 1995; 88:15–19.
Article
6. Chen WR, Adams RL, Bartels KE, Nordquist RE. Chromophore-enhanced in vivo tumor cell destruction using an 808-nm diode laser. Cancer Lett. 1995; 94:125–131.
Article
7. Chen WR, Adams RL, Higgins AK, Bartels KE, Nordquist RE. Photothermal effects on murine mammary tumors using indocyanine green and an 808-nm diode laser: an in vivo efficacy study. Cancer Lett. 1996; 98:169–173.
Article
8. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest. 1960; 39:592–600.
Article
9. Dernell WS, Withrow SJ, Kuntz CA, Powers BE. Principles of treatment for soft tissue sarcoma. Clin Tech Small Anim Pract. 1998; 13:59–64.
Article
10. Diven DG, Pohl J, Motamedi M. Dye-enhanced diode laser photothermal ablation of skin. J Am Acad Dermatol. 1996; 35:211–215.
Article
11. Dougherty TJ, Thoma RE, Boyle DG, Weishaupt KR. Interstitial photoradiation therapy for primary solid tumors in pet cats and dogs. Cancer Res. 1981; 41:401–404.
12. Dzurinko VL, Gurwood AS, Price JR. Intravenous and indocyanine green angiography. Optometry. 2004; 75:743–755.
Article
13. Ettinger SN. Principles of treatment for soft-tissue sarcomas in the dog. Clin Tech Small Anim Pract. 2003; 18:118–122.
Article
14. Gerweck LE. Modification of cell lethality at elevated temperatures: the pH effect. Radiat Res. 1977; 70:224–235.
Article
15. Hahn GM, Braun J, Har-Kedar I. Thermochemotherapy: synergism between hyperthermia (42-43°) and adriamycin (or bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci U S A. 1975; 72:937–940.
Article
16. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res. 1979; 39:2264–2268.
17. Hirche C, Murawa D, Mohr Z, Kneif S, Hünerbein M. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat. 2010; 121:373–378.
Article
18. Hirano T, Kohno E, Gohto Y, Obana A. Singlet oxygen generation due to ICG irradiation. Photomed Photobiol. 2006; 28:15–16.
19. Hojo T, Nagao T, Kikuyama M, Akashi S, Kinoshita T. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast. 2010; 19:210–213.
Article
20. Kuntz CA, Dernell WS, Powers BE, Devitt C, Straw RC, Withrow SJ. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). J Am Vet Med Assoc. 1997; 211:1147–1151.
21. Liptak JM, Forrest LJ. Soft tissue sarcoma. In : Withrow SJ, Vail DM, Page RL, editors. Small Animal Clinical Oncology. 5th ed. St. Louis: Elsevier Saunders;2012. p. 356–380.
22. McChesney SL, Gillette EL, Dewhirst MW, Withrow SJ. Influence of WR 2721 on radiation response of canine soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 1986; 12:1957–1963.
Article
23. Mamoon AM, Gamal-Eldeen AM, Ruppel ME, Smith RJ, Tsang T, Miller LM. In vitro efficiency and mechanistic role of indocyanine green as photodynamic therapy agent for human melanoma. Photodiagnosis Photodyn Ther. 2009; 6:105–116.
Article
24. Marmor JB. Interactions of hyperthermia and chemotherapy in animals. Cancer Res. 1979; 39:2269–2276.
25. Newell KJ, Tannock IF. Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide-3 chlorophenylhydrazone. Cancer Res. 1989; 49:4477–4482.
26. Ogilvie GK, Reynolds HA, Richardson RC, Withrow SJ, Norris AM, Henderson RA, Klausner JS, Fowler JD, McCaw D. Phase II evaluation of doxorubicin for treatment of various canine neoplasms. J Am Vet Med Assoc. 1989; 195:1580–1583.
27. Ogilvie GK, Obradovich JE, Elmslie RE, Vail DM, Moore AS, Straw RC, Dickinson K, Cooper MF, Withrow SJ. Efficacy of mitoxantrone against various neoplasms in dogs. J Am Vet Med Assoc. 1991; 198:1618–1621.
28. Okamoto Y, Ogura K, Okamura Y, Ishii H, Sakata I, Hakamada K, Miyaki S, Nakajima S, Minami S. Canine hemangiopericytoma treated by combination of surgical resection and photodynamic therapy with novel photosensitizer, PAD-S31. Jap J Vet Anesth Surg. 2005; 36:69–73.
Article
29. Osaki T, Takagi S, Hoshino Y, Okumura M, Kadosawa T, Fujinaga T. Efficacy of antivascular photodynamic therapy using benzoporphyrin derivative monoacid ring A (BPD-MA) in 14 dogs with oral and nasal tumors. J Vet Med Sci. 2009; 71:125–132.
Article
30. Peaston AE, Leach MW, Higgins RJ. Photodynamic therapy for nasal and aural squamous cell carcinoma in cats. J Am Vet Med Assoc. 1993; 202:1261–1265.
31. Radzi R, Osaki T, Tsuka T, Imagawa T, Minami S, Okamoto Y. Morphological study in B16F10 murine melanoma cells after photodynamic hyperthermal therapy with indocyanine green (ICG). J Vet Med Sci. 2012; 74:465–472.
Article
32. Radzi R, Osaki T, Tsuka T, Imagawa T, Minami S, Nakayama Y, Okamoto Y. Photodynamic hyperthermal therapy with indocyanine green (ICG) induces apoptosis and cell cycle arrest in B16F10 murine melanoma cells. J Vet Med Sci. 2012; 74:545–551.
Article
33. Reeds KB, Ridgway TD, Higbee RG, Lucroy MD. Non-coherent light for photodynamic therapy of superficial tumours in animals. Vet Comp Oncol. 2004; 2:157–163.
Article
34. Roberts WG, Klein MK, Loomis M, Weldy S, Berns MW. Photodynamic therapy of spontaneous cancers in felines, canines, and snakes with chloro-aluminum sulfonated phthalocyanine. J Natl Cancer Inst. 1991; 83:18–23.
Article
35. Tanabe S, Yamamaguchi M, Iijima M, Nakajima S, Sakata I, Miyaki S, Takemura T, Furuoka H, Kobayashi Y, Matsui T, Uzuka Y, Sarashina T. Fluorescence detection of a new photosensitizer, PAD-S31, in tumour tissues and its use as a photodynamic treatment for skin tumours in dogs and a cat: a preliminary report. Vet J. 2004; 167:286–293.
Article
36. Wike-Hooley JL, van den Berg AP, van der Zee J, Reinhold HS. Human tumour pH and its variation. Eur J Cancer Clin Oncol. 1985; 21:785–791.
Article
Full Text Links
  • JVS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr